We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
132 hedge funds and large institutions have $241M invested in Esperion Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
501% more call options, than puts
Call options by funds: $7.04M | Put options by funds: $1.17M
43% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 30
4% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 28
1% less funds holding
Funds holding: 133 → 132 (-1)
10% less capital invested
Capital invested by funds: $268M → $241M (-$26.8M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
101.72% less ownership
Funds ownership: 184.38% → 82.66% (-102%)
Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
43
Reduced
30
Closed
28
Calls
$7.04M
Puts
$1.17M
Net Calls
+$5.87M
Net Calls Change
+$4.26M
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.55M |
| 2 |
BlackRock
New York
|
+$6.53M |
| 3 |
Millennium Management
New York
|
+$3.92M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.13M |
| 5 |
JP Morgan Chase
New York
|
+$2.73M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$25M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$7.3M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.03M |
| 4 |
HF
HRT Financial
New York
|
-$1.18M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.06M |
